AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) Short Interest Update

AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPCGet Rating) was the target of a large decline in short interest in the month of April. As of April 30th, there was short interest totalling 65,300 shares, a decline of 38.0% from the April 15th total of 105,300 shares. Based on an average daily trading volume, of 1,220,000 shares, the short-interest ratio is currently 0.1 days.

NASDAQ ANPC opened at $0.30 on Friday. AnPac Bio-Medical Science has a one year low of $0.20 and a one year high of $5.66. The company has a 50-day simple moving average of $0.42 and a 200-day simple moving average of $0.99.

An institutional investor recently bought a new position in AnPac Bio-Medical Science stock. Virtu Financial LLC purchased a new stake in AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPCGet Rating) in the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 34,691 shares of the company’s stock, valued at approximately $42,000. Virtu Financial LLC owned 0.23% of AnPac Bio-Medical Science as of its most recent filing with the SEC. Hedge funds and other institutional investors own 1.53% of the company’s stock.

AnPac Bio-Medical Science Company Profile (Get Rating)

AnPac Bio-Medical Science Co, Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China. It offers cancer differentiation analysis devices and physical checkup package services.

Read More

Receive News & Ratings for AnPac Bio-Medical Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AnPac Bio-Medical Science and related companies with MarketBeat.com's FREE daily email newsletter.